Literature DB >> 15180330

Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

V Berezowski1, C Landry, S Lundquist, L Dehouck, R Cecchelli, M P Dehouck, L Fenart.   

Abstract

PURPOSE: The objective of the current study was to investigate whether blood-brain barrier (BBB) permeability studies in vitro could be accelerated by running several compounds together in the same experiment.
METHODS: To address this question, we compared the transport of six compounds run separately with the results of the same compounds run together (cocktails).
RESULTS: The study clearly demonstrated that the outcome of the experiments were totally different depending on the strategy used. Furthermore, the study highlights the importance of having the resistance to drug transport offered by filters without cells under control, as the filter membrane itself can be the rate-limiting step for some compounds; in addition, there is always a potential risk of interactions between molecules in cocktails as well as drug-drug interaction at the level of BBB transporters. In this study, the presence of several P-glycoprotein substrates in the drug cocktail was found to cause breakdown of the BBB.
CONCLUSIONS: The results demonstrate that unless a strategy that involves running several compounds in the same experiment is properly validated, the results are of little predictive value.

Mesh:

Substances:

Year:  2004        PMID: 15180330     DOI: 10.1023/b:pham.0000026424.78528.11

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  High-throughput caco-2 cell permeability screening by cassette dosing and sample pooling approaches using direct injection/on-line guard cartridge extraction/tandem mass spectrometry.

Authors:  H Z Bu; M Poglod; R G Micetich; J K Khan
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

2.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

3.  Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis.

Authors:  M Markowska; R Oberle; S Juzwin; C P Hsu; M Gryszkiewicz; A J Streeter
Journal:  J Pharmacol Toxicol Methods       Date:  2001 Jul-Aug       Impact factor: 1.950

4.  Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes.

Authors:  M B BORNSTEIN
Journal:  Lab Invest       Date:  1958 Mar-Apr       Impact factor: 5.662

5.  Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models.

Authors:  M P Dehouck; P Jolliet-Riant; F Brée; J C Fruchart; R Cecchelli; J P Tillement
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

6.  Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Authors:  L Fenart; V Buée-Scherrer; L Descamps; C Duhem; M G Poullain; R Cecchelli; M P Dehouck
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

7.  An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro.

Authors:  M P Dehouck; S Méresse; P Delorme; J C Fruchart; R Cecchelli
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

8.  Intestinal absorption screening of mixtures from combinatorial libraries in the Caco-2 model.

Authors:  E W Taylor; J A Gibbons; R A Braeckman
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

9.  Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures.

Authors:  J Booher; M Sensenbrenner
Journal:  Neurobiology       Date:  1972

10.  Deciphering the fluorescence signature of daunomycin and doxorubicin.

Authors:  K K Karukstis; E H Thompson; J A Whiles; R J Rosenfeld
Journal:  Biophys Chem       Date:  1998-07-27       Impact factor: 2.352

View more
  7 in total

1.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

Review 2.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

3.  The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.

Authors:  Urban Fagerholm
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

Review 4.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

Review 5.  In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Authors:  Christopher A Palmiotti; Shikha Prasad; Pooja Naik; Kaisar M D Abul; Ravi K Sajja; Anilkumar H Achyuta; Luca Cucullo
Journal:  Pharm Res       Date:  2014-08-07       Impact factor: 4.200

Review 6.  Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.

Authors:  Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

7.  Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.

Authors:  P Marc D Watson; Judy C Paterson; George Thom; Ulrika Ginman; Stefan Lundquist; Carl I Webster
Journal:  BMC Neurosci       Date:  2013-06-18       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.